Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.
Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, Michler RE, Kron IL; CTSN. Acker MA, et al. Among authors: argenziano m. N Engl J Med. 2014 Jan 2;370(1):23-32. doi: 10.1056/NEJMoa1312808. Epub 2013 Nov 18. N Engl J Med. 2014. PMID: 24245543 Free PMC article. Clinical Trial.
Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery.
Salisbury AC, Grantham JA, Brown WM, Ballard WL, Allen KB, Kirtane AJ, Argenziano M, Yeh RW, Khabbaz K, Lasala J, Kachroo P, Karmpaliotis D, Moses J, Lombardi WL, Nugent K, Ali Z, Gosch KL, Spertus JA, Kandzari DE; OPTIMUM Investigators. Salisbury AC, et al. Among authors: argenziano m. JACC Cardiovasc Interv. 2023 Feb 13;16(3):261-273. doi: 10.1016/j.jcin.2023.01.003. JACC Cardiovasc Interv. 2023. PMID: 36792252 Free article.
Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
Hirai T, Grantham JA, Kandzari DE, Ballard W, Brown WM, Allen KB, Kirtane AJ, Argenziano M, Yeh RW, Khabbaz K, Lombardi W, Lasala J, Kachroo P, Karmpaliotis D, Gosch KL, Salisbury AC; OPTIMUM Study Group. Hirai T, et al. Among authors: argenziano m. Catheter Cardiovasc Interv. 2023 Nov;102(5):814-822. doi: 10.1002/ccd.30834. Epub 2023 Sep 7. Catheter Cardiovasc Interv. 2023. PMID: 37676058
The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Balducci D, Montori M, Martini F, Valvano M, De Blasio F, Argenziano ME, Tarantino G, Benedetti A, Bendia E, Marzioni M, Maroni L. Balducci D, et al. Among authors: argenziano me. Cancers (Basel). 2024 Mar 30;16(7):1372. doi: 10.3390/cancers16071372. Cancers (Basel). 2024. PMID: 38611050 Free PMC article. Review.
Biologically-informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post-treatment glioblastoma.
Wang H, Argenziano MG, Yoon H, Boyett D, Save A, Petridis P, Savage W, Jackson P, Hawkins-Daarud A, Tran N, Hu L, Al Dalahmah O, Bruce JN, Grinband J, Swanson KR, Canoll P, Li J. Wang H, et al. Among authors: argenziano mg. Res Sq [Preprint]. 2024 Mar 27:rs.3.rs-3891425. doi: 10.21203/rs.3.rs-3891425/v1. Res Sq. 2024. PMID: 38585856 Free PMC article. Preprint.
342 results